Table of Contents

Clinical Studies

• Open Access

  Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study

  MINNA KANKURI-TAMMILEHTO, LAURA PERASTO, SEPPO PYRHONEN and EEVA SALMINEN

  Anticancer Research June 2023, 43 (6) 2645-2657; DOI: https://doi.org/10.21873/anticanres.16431
• Open Access

  Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis

  PIETRO FAMILIARI, PIERFRANCESCO LAPOLLA, VERONICA PICOTTI, MAURO PALMIERI, ALESSANDRO PESCE, GIULIA CAROSI, MICHELA RELUCENTI, STEFANIA NOTTOLA, FRANCESCA GIANNO, SIMONE MINASI, MANILA ANTONELLI, ALESSANDRO FRATI, ANTONIO SANTORO, GIANCARLO D’ANDREA, PLACIDO BRUZZANITI and BIAGIA LA PIRA

  Anticancer Research June 2023, 43 (6) 2659-2670; DOI: https://doi.org/10.21873/anticanres.16432
• Open Access

  Single Nucleotide Polymorphism Directed Antiemetic Treatment in Women With Breast Cancer Treated With Neo- or Adjuvant Chemotherapy: A Randomised Multicentre Phase II Study. (EudraCT: 2015–000658-39)

  DELMY OLIVA, BENGT-ÅKE ANDERSSON, LEVAR SHAMOUN, NONGNIT LEWIN, MATS P. NILSSON, ELSY-BRITT SCHILDT, LISA FUST, ULRIKA ÅSENLUND, GUNILLA SELLERSTAM, ELLINOR ELINDER, LENA SHARP and FREDDI LEWIN

  Anticancer Research June 2023, 43 (6) 2671-2681; DOI: https://doi.org/10.21873/anticanres.16433
• Open Access

  KRAS Mutation Analysis Using Cell-free DNA of Pancreatic Cancer

  YORIHIKO TAKASE, YOSHIKI NAITO, AKIHIKO KAWAHARA, YOSHINOBU OKABE, EIJI SADASHIMA, HIDEYUKI ABE and JUN AKIBA

  Anticancer Research June 2023, 43 (6) 2683-2690; DOI: https://doi.org/10.21873/anticanres.16434
• Open Access

  Safety of Carbon-ion Radiotherapy for Prostate Cancer After Rectal Cancer Surgery

  YOSUKE TAKAKUSAGI, HIROAKI KOGE, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, DAISAKU YOSHIDA, TADASHI KAMADA and HIROYUKI KATOH

  Anticancer Research June 2023, 43 (6) 2691-2695; DOI: https://doi.org/10.21873/anticanres.16435
• You have access

  Clinical Significance of Pre-treatment Circumferential Tumor Location in Patients With cStage IB-III Esophageal Squamous Cell Cancer

  SHINSUKE NAGASAWA, TAKASHI OSHIMA, KENTARO HARA, MASATO NAKAZONO, YUTA KUMAZU, TORU AOYAMA, TAKANOBU YAMADA, TAKASHI OGATA, YASUSHI RINO, AYA SAITO, TOMOYUKI YOKOSE and HEIKE I. GRABSCH

  Anticancer Research June 2023, 43 (6) 2697-2705; DOI: https://doi.org/10.21873/anticanres.16436
• Open Access

  Clinicopathological Factors Influencing Resection Margin Involvement During Mohs Micrographic Surgery for Skin Tumors

  JINAH CHU, YUMIN CHUNG, SEOUNG WAN CHAE, YOUNG-JUN CHOI, HYUN-SOO KIM and SUNG-IM DO

  Anticancer Research June 2023, 43 (6) 2707-2715; DOI: https://doi.org/10.21873/anticanres.16437
• You have access

  Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study

  TAKURO OKADA, CHIHIRO FUSHIMI, TAKASHI MATSUKI, KUNIHIKO TOKASHIKI, HIDEAKI TAKAHASHI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KENJI HANYU, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, TATSUO MASUBUCHI, YUICHIRO TADA, KOKI MIURA, GO OMURA, TAKU YAMASHITA, NOBUHIKO ORIDATE and KIYOAKI TSUKAHARA

  Anticancer Research June 2023, 43 (6) 2717-2724; DOI: https://doi.org/10.21873/anticanres.16438
• Open Access

  Identification of Patients With Glioblastoma Who May Benefit from Hypofractionated Radiotherapy

  OKSANA ZEMSKOVA, NATHAN Y. YU, PETER TRILLENBERG, MATTEO M. BONSANTO, JAN LEPPERT and DIRK RADES

  Anticancer Research June 2023, 43 (6) 2725-2732; DOI: https://doi.org/10.21873/anticanres.16439
• You have access

  Dose-dependent Effects of Unintended Splenic Irradiation After Neoadjuvant Radiochemotherapy for Esophageal Cancer

  EREN CELIK, CHRISTIAN BAUES, MAIKE TROMMER, JIAQI FAN, LUKAS NADJIRI, JOHANNES ROSENBROCK and PHILIPP LINDE

  Anticancer Research June 2023, 43 (6) 2733-2739; DOI: https://doi.org/10.21873/anticanres.16440
• You have access

  Robotic Retroperitoneal Versus Transperitoneal Partial Nephrectomy: Outcomes and Learning Curve

  NICOLAS FISCHER, TOBIAS KOWALKE, MANUELA A. HOFFMANN and DANIEL PORRES

  Anticancer Research June 2023, 43 (6) 2741-2747; DOI: https://doi.org/10.21873/anticanres.16441
• You have access

  Impact of Minimally Invasive Intrathoracic Hand-sewn Esophago-gastric Anastomosis in Esophagectomy for Cancer

  ALEXANDROS CHARALABOPOULOS, SPYRIDON DAVAKIS, PANAGIOTIS SAKARELLOS, EFSTRATIA MPAILI, ELENI SARLANI, STRATIGOULA SAKELLARIOU, DIMITRIOS ZIOGAS, MARIA THEOCHARI and THEODOROS LIAKAKOS

  Anticancer Research June 2023, 43 (6) 2749-2755; DOI: https://doi.org/10.21873/anticanres.16442
• You have access

  Treatment Outcomes After Higher-dose Fractionated Stereotactic Radiotherapy (FSRT) Alone for 1-4 Brain Metastases

  LEONIE JOHANNWERNER, ELISA M. WERNER, STEFAN JANSSEN, NATHAN Y. YU and DIRK RADES

  Anticancer Research June 2023, 43 (6) 2757-2762; DOI: https://doi.org/10.21873/anticanres.16443
• Open Access

  Stereotactic Radiotherapy or Whole-Brain Irradiation Plus Simultaneous Integrated Boost After Resection of Brain Metastases

  DIRK RADES, LEONIE JOHANNWERNER, NATHAN Y. YU and JAN GLIEMROTH

  Anticancer Research June 2023, 43 (6) 2763-2770; DOI: https://doi.org/10.21873/anticanres.16444
• Open Access

  Possible False Results With cobas^® EGFR Mutation Test v2 and Oncomine Dx Target Test for EGFR Mutation

  KENSUKE KANAOKA, AKIHIRO TAMIYA, YUJI INAGAKI, YOSHIHIKO TANIGUCHI, KEIKO NAKAO, MAIKO TAKEDA, YOSHINOBU MATSUDA, KYOICHI OKISHIO and SHIGEKI SHIMIZU

  Anticancer Research June 2023, 43 (6) 2771-2776; DOI: https://doi.org/10.21873/anticanres.16445
• Open Access

  Clinical Outcomes of Intensity-modulated Carbon-ion Radiotherapy for Bone and Soft Tissue Tumors

  YOSUKE TAKAKUSAGI, HIROAKI KOGE, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, DAISAKU YOSHIDA, TADASHI KAMADA and HIROYUKI KATOH

  Anticancer Research June 2023, 43 (6) 2777-2781; DOI: https://doi.org/10.21873/anticanres.16446
• You have access

  Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib

  MIDORI MORITA, ASAKO OOE, WATARU ISHII, AKIRA WATANABE, CHISE MATSUI, YUKA OKUYAMA, SAE KITANO, CHIKAGE KATO, MIE ONISHI, KOICHI SAKAGUCHI and YASUTO NAOI

  Anticancer Research June 2023, 43 (6) 2783-2789; DOI: https://doi.org/10.21873/anticanres.16447
• You have access

  Toxic Effects of Volume-modulated Arc Therapy for Esophageal Squamous Cell Cancer: Preliminary Clinical Results

  DAISUKE SHIGENAGA, OGINO ICHIRO, SHIGENOBU WATANABE and MASAHARU HATA

  Anticancer Research June 2023, 43 (6) 2791-2798; DOI: https://doi.org/10.21873/anticanres.16448
• You have access

  Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients

  HELENA LINARDOU, SOFIA LAMPAKI, GEORGIA-ANGELIKI KOLIOU, ATHANASSIOS VOZIKIS, ANASTASIOS BOUTIS, ADAMANTIA NIKOLAIDI, IOANNIS KONTOGIORGOS, PAVLOS PAPAKOTOULAS, ATHINA CHRISTOPOULOU, DIONYSIOS SPYRATOS, DIMITRIOS BAFALOUKOS, AMANDA PSYRRI, ANASTASIOS GRIVAS, ANNA KOUMARIANOU, KARYOFYLLIS TSIAKITZIS, DAVIDE MAURI, GEORGIOS RIGAKOS, GERASIMOS ARAVANTINOS, PANAGIOTIS PAPANTONIOU, GEORGIOS OIKONOMOPOULOS, ELENA FOUNTZILAS, MARGARITA-IOANNA KOUFAKI, MARIA KAPARELOU, ELIAS LIOLIS, GIANNIS MOUNTZIOS, PARIS KOSMIDIS, GEORGE FOUNTZILAS and EPAMINONDAS SAMANTAS

  Anticancer Research June 2023, 43 (6) 2799-2812; DOI: https://doi.org/10.21873/anticanres.16449
• You have access

  Lymph Node Metastasis in Extraperitoneal Rectal Cancer After Neoadjuvant Therapy: An Unsolved Problem?

  ALICE LA FRANCA, EDOARDO MARIA MUTTILLO, ISABELLA MADAFFARI, FANNY MASSIMI, GIUSEPPE LONGO, ALICE CECCACCI, ILARIA ANGELICONE, FLAVIA DE GIACOMO, ISABELLA SPERDUTI, GENOVEFFA BALDUCCI, MATTIA FALCHETTO OSTI and PAOLO MERCANTINI

  Anticancer Research June 2023, 43 (6) 2813-2820; DOI: https://doi.org/10.21873/anticanres.16450
• You have access

  Relationship of Inflammatory Parameters and Nutritional Status in Cancer Patients

  DANIELA SAMBATARO, MARIA ROSARIA POLITI, ANGELA MESSINA, LINDA SCARPELLO, SEBASTIANO MESSINA, ROSSELLA GUGGINO, CARLO CARNAGHI, RICCARDO CACCIALANZA and VITTORIO GEBBIA

  Anticancer Research June 2023, 43 (6) 2821-2829; DOI: https://doi.org/10.21873/anticanres.16451
• You have access

  Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer

  KEI HAYASHI, MITSUHIRO FURUTA, KYOKO FURUSAWA, TOMOMI HAMAGUCHI, MAMORU WATANABE, YASUHIRO INOKUCHI, SHIZUNE ONUMA, ITARU HASHIMOTO, HIDEAKI SUEMATSU, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TAKANOBU YAMADA, AKIFUMI NOTSU, TAKASHI OGATA, TAKASHI OSHIMA, NOZOMU MACHIDA, JUNJI FURUSE and SHIN MAEDA

  Anticancer Research June 2023, 43 (6) 2831-2840; DOI: https://doi.org/10.21873/anticanres.16452
• You have access

  Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer

  KOHEI KASAHARA, CHIKARA KUNISAKI, SHO SATO, HIROKI KONDO, MASAZUMI TAKAHASHI, YUKO TAMURA, NOBUHIRO TSUCHIYA, YUSAKU TANAKA, KEI SATO, JUN KIMURA, TAKASHI KOSAKA, HIDETAKA ONO, HIROCHIKA MAKINO, HIROTOSHI AKIYAMA and ITARU ENDO

  Anticancer Research June 2023, 43 (6) 2841-2850; DOI: https://doi.org/10.21873/anticanres.16453
• You have access

  Long-term Outcomes of Early-stage Non-stomach Gastrointestinal Mucosa-associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy

  EIKO ITO, ICHIRO OGINO, MADOKA SUGIURA, SHIGENOBU WATANABE, YOSHIBUMI TAYAMA, SHOKO TAKANO and MASAHARU HATA

  Anticancer Research June 2023, 43 (6) 2851-2857; DOI: https://doi.org/10.21873/anticanres.16454
• You have access

  Impact of Radiation Dose on Treatment of Maxillary Cancer With Superselective Intra-arterial Cisplatin With Radiotherapy

  KENTA KONISHI, MIKA KAMIYA, KEIICHI OHIRA, MASANORI HIRATA, KOHEI WAKABAYASHI, TSUTOMU IKENOHIRA, TAKASHI KOSUGI, TAKASUKE USHIO, ATSUSHI IMAI, DAIKI MOCHIZUKI, YUKI YAMAGUCHI, YUKICHI TANAHASHI, KIYOSHI MISAWA, SATOSHI GOSHIMA and KATSUMASA NAKAMURA

  Anticancer Research June 2023, 43 (6) 2859-2864; DOI: https://doi.org/10.21873/anticanres.16455
• You have access

  Clinicopathological Characteristics and Prognosis of Mucinous Gastric Cancer

  KEISUKE KOMORI, KAZUKI KANO, SHUJI ANDO, HAYATO WATANABE, KOSUKE TAKAHASHI, YUKIO MAEZAWA, HIROHITO FUJIKAWA, SHO SAWAZAKI, MASAKATSU NUMATA, TORU AOYAMA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, TAKASHI OGATA and TAKASHI OSHIMA

  Anticancer Research June 2023, 43 (6) 2865-2871; DOI: https://doi.org/10.21873/anticanres.16456
• You have access

  Successful Treatment of Refractory Enterocutaneous Fistula After Esophagectomy Using Soft Coagulation by an Endoscopic and Percutaneous Approach: A Case Report

  SHUHEI ITO, KIPPEI OHGAKI, TETSURO KAWAZOE, HUANLIN WANG, YASUHARU OKAMOTO, EISUKE ADACHI and YOICHI IKEDA

  Anticancer Research June 2023, 43 (6) 2873-2877; DOI: https://doi.org/10.21873/anticanres.16457
• You have access

  CDX2-positive Cancer of Unknown Primary With Upper-body Paralysis Was Dramatically Improved by Colorectal Cancer Chemotherapy

  HIDEKO AKAGI, YUSAKU TANAKA, KOHEI WADA, MIANAMI TAKAHASHI, KOUDAI YOSHIDA and HIDEHARU DOMOTO

  Anticancer Research June 2023, 43 (6) 2879-2884; DOI: https://doi.org/10.21873/anticanres.16458
• Open Access

  Book Reviews

  Anticancer Research June 2023, 43 (6) 2885-2888; DOI: https://doi.org/10.21873/anticanres.16459